Saturday, 19 Sep 2026
Empowering Chinese Pharma’s Global Expansion
Contact US
Home
About US
Policy Hub
Categories
Drug
Company
Deals
Policy / Regulatory
Medical Device
R&D
Legal / IP
Digital
Privacy Policy
Contact US
My News
Cancer
Clinical trial approval / initiation
Product approvals
Finance
Clinical trial results
ADC / XDC
Finanical Reports
Biotech
Market approval filings
PD-1/L1
Read History
Search
Pages
Home
Blog Index
POLICY HUB
Contact Us
Personalized
Read History
Categories
Company
Drug
Policy / Regulatory
Medical Device
R&D
Digital
Legal / IP
Deals
Have an existing account?
Sign In
Follow US
Fineline Cube
Follow:
14436
Articles
Company
Deals
Aidea Pharma and China Meheco Partner to Expand Medical and Pharmaceutical Services
January 6, 2025
Company
3SBio Inc. Reports 7.5% Revenue Growth in 2022 Financials
January 6, 2025
Company
Deals
Joincare Pharmaceutical Acquires Rights to TaiGen’s PA Endonuclease Inhibitor TG-1000
January 6, 2025
Company
Drug
Reistone Biopharma’s Ivarmacitinib Shows Positive Results in Phase III QUARTZ3 Study
January 6, 2025
Company
Deals
Sinopharm Forms Joint Ventures with Foreign Medical Equipment Firms
January 6, 2025
Company
BeiGene Marks Topping Off of New Biologics Facility in New Jersey
January 6, 2025
Company
Deals
Roche Partners with China Resource Medicine to Promote Xofluza in China
January 6, 2025
Company
Deals
Jacobio Pharma Partners with Merck to Evaluate CD73 mAb and Keytruda Combination
January 6, 2025
Company
Drug
Yifan Pharmaceutical’s F-652 Cleared for Phase II Trial in Alcoholic Hepatitis
January 6, 2025
Company
Deals
BioNTech Acquires Global Rights to OncoC4’s Anti-CTLA-4 Antibody ONC-392
January 6, 2025
Company
Deals
Cygnus Bio Raises Millions in Series C+ Financing for Sequencing Technology
January 6, 2025
Company
Deals
L&L Biopharma Completes Series B Financing for Tumor Immunotherapy Development
January 6, 2025
1
2
…
1,006
1,007
1,008
1,009
1,010
…
1,202
1,203
Welcome to Fineline Cube!
Username or Email Address
Password
Remember me
Lost your password?